Efficacy and Safety Study of Moxidectin in Adults With Scabies | MicrobiomeTrials← Back to trialsNCT05875441
Efficacy and Safety Study of Moxidectin in Adults With Scabies
CompletedPHASE2INTERVENTIONAL
Trial Details
Start: 2023-11-23Est. Completion: 2024-11-27
Enrollment target: 200 participants Locations- LA Universal Research Center, Inc, Los Angeles, California, United States
- Evolution Clinical Trials, Miami, Florida, United States
- Advanced Care and Clinical Trials, LLC, Miami, Florida, United States
- Medical Research of Westchester, Inc, Miami, Florida, United States
- Affinity Clinical Research LLC, Tampa, Florida, United States
- Instituto Dermatologico Dominicano y Cirugia de Piel, Santo Domingo Oeste, Santo Domingo Province, Dominican Republic
- Vargas Clinic, San Salvador, San Salvador Department, El Salvador
- Derclinic, San Pedro Sula, Cortez, Honduras
- Hospital y Clinica Bendana, San Pedro Sula, Cortés Department, Honduras
Other microbiome trials you might be interested in
ScabiesAtopic DermatitisSecondary Bacterial Skin Infection
This prospective observational study will evaluate the microbiological profile of secondary bacterial infection and nasa…
Istanbul, Turkey (Türkiye)Est. completion Mar 2027
Health LiteracyHealth Screening
Health literacy (HL) is defined by the World Health Organization (WHO) as "the achievement of a level of knowledge, pers…
Düzce, Turkey (Türkiye)Completed May 13, 2026